XPhyto Therapeutics Corp.



StageZero Life Sciences Ltd.
Latest Comments
image_pdfimage_print

Hugh Rogers on the European approval of the XPhyto Therapeutics point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system

In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE: XPHY | […]


XPhyto gains traction in European market with ‘one of the fastest PCR-based COVID-19 tests currently approved’

XPhyto Therapeutics Corp. (CSE: XPHY | OTCQB: XPHYF | FSE: 4XT) (“XPhyto”) is a next generation bioscience company beginning a […]


XPhyto Therapeutics is looking to hit a home run with their innovative medical products and therapies

New therapies and diagnostics in the pharmaceutical and medical industries can be a very lucrative area. To be successful a […]


XPhyto Therapeutics Hugh Rogers on the fastest and most portable PCR test available

In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE: XPHY […]


Xphyto’s disposable saliva test with sample-to-results in less than 15 minutes is turning heads

“May you live in interesting times” is widely reported as being a curse of ancient Chinese origin but it is […]


XPhyto Therapeutics moving forward from successful prototype testing of saliva virus test

Non-invasive test can detect viral RNA in asymptomatic patients XPhyto Therapeutics Corp. (CSE: XPHY | OTCQB: XPHYF | FSE: 4XT) […]


Rapid and accurate testing the key to a return to normalcy

And here are three companies working on it. Imagine a global pandemic caused by a new virus. Apparently it has […]